Relevance of KISS1 gene polymorphisms in susceptibility to polycystic ovary syndrome and its associated endocrine and metabolic disturbances

References

• Wolf WM, Wattick RA, Kinkade ON, et al. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health. 2018;15:1–13.
   Web of Science ®Google Scholar
• Trent ME, Rich M, Austin SB, et al. Quality of life in adolescent girls with polycystic ovary syndrome. Arch Pediatr Adolesc Med. 2002;156:556–560.
   PubMedGoogle Scholar
• Leo VD, Musacchio MC, Cappelli V, et al. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol. 2016;14:38: 1–17.
   Web of Science ®Google Scholar
• Witchel SF, Tena-Sempere M. The Kiss1 system and polycystic ovary syndrome: lessons from physiology and putative pathophysiologic implications. Fertil Steril. 2013;100:12–22.
   PubMed Web of Science ®Google Scholar
• Chaudhari N, Chaudhari N, Dawalbhakta M, et al. GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile. Reprod Biol Endocrinol. 2018 Apr 11;16:37.
   PubMed Web of Science ®Google Scholar
• d’Anglemont de Tassigny X, Colledge WH. The role of kisspeptin signaling in reproduction. Physiology. 2010;25:207–217.
   PubMed Web of Science ®Google Scholar
• Pinilla L, Aguilar E, Dieguez C, et al. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev. 2012;92:1235–1316.
   PubMed Web of Science ®Google Scholar
• Nejad SZ, Tehrani FR, Vakili AZ. The role of kisspeptin in female reproduction. Int J Endocrinol Metab. 2017;15:1–11.
   Web of Science ®Google Scholar
• Albalawi FS, Daghestani MH, Daghestani MH, et al. rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in Saudi women. J Biomed Sci. 2018;25:1–6.
   PubMed Web of Science ®Google Scholar
• Umayal B, Muneeswaran K, Wijesundera WSS, et al. Association of Kiss1 and GPR54 Gene Polymorphisms with Polycystic Ovary Syndrome among Sri Lankan Women. Biomed Res Int. 2019;2019:1–10.
   Web of Science ®Google Scholar
• Dantas WS, Gualano B, Rocha MP, et al. Metabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissue. Hindawi Publishing Corporation. Sci World J. 2013;2013:1–7.
   Google Scholar
• Dennett CC, Simon J. The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment. Diabetes Spectr. 2015;28:116–120.
   PubMedGoogle Scholar
• Yao K, Bian C, Zhao X. Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: aggravated complication of pregnancy. Exp Ther Med. 2017;14:1271–1276.
   PubMed Web of Science ®Google Scholar
• Marshall JC, Dunaif A. All women with PCOS should be treated for insulin resistance. Fertil Steril. 2012;97:18–22.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Young MC. Dyslipidemia in women with polycystic ovary syndrome. Obstet Gynecol Sci. 2013;56:137–142.
   PubMedGoogle Scholar
• Svendsen PF, Ni Las L, Nørgaard K, et al. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod. 2008;23:2113–2121.
   PubMed Web of Science ®Google Scholar
• Kandaraki E, Christakou C, Diamanti-Kandarakis E. Metabolic syndrome and PCOS. Arq Bras Endocrinol Metab. 2009;53:227–237.
   PubMedGoogle Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
   Web of Science ®Google Scholar
• Crespo RP, Bachega TAS, Mendonca BB, et al. An update of genetic basis of PCOS pathogenesis. Arch Endocrinol Metab. 2018;62:352–361.
   PubMed Web of Science ®Google Scholar
• Katulski K, Podfigurna A, Czyzyk A, et al. Kisspeptin and LH pulsatile temporal coupling in PCOS patients. Endocrine. 2018;61:149–157.
   PubMed Web of Science ®Google Scholar
• Chun S. Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome. Clin Exp Reprod Med. 2014;41:86–91.
   PubMedGoogle Scholar
• Huang J, Ni R, Chen X, et al. Metabolic abnormalities in adolescents with polycystic ovary syndrome in south china. Reprod Biol Endocrinol. 2010;8:142.
   PubMed Web of Science ®Google Scholar
• Valkenburg O, Uitterlinden AG, Piersma D, et al. Genetic polymorphisms of GnRH and gonadotrophic hormone affect the phenotype of polycystic ovary syndrome receptors. Hum Reprod. 2009;24:2014–2022.
   PubMed Web of Science ®Google Scholar
• Silveira LG, Noel SD, Silveira-Neto AP, et al. Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab. 2010 95:2276–2280.
   PubMed Web of Science ®Google Scholar
• Mayr C. What are 3ʹ UTRs doing? Cold Spring Harb Perspect Biol. 2019;11:pii: a034728.
   PubMed Web of Science ®Google Scholar
• Gorkem U, Togrul C, Arslan E, et al. Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome? Gynecol Endocrinol. 2018;34:157–160.
   PubMed Web of Science ®Google Scholar
• Emekci Ozay O, Ozay AC, Acar B, et al. Role of kisspeptin in polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2016;32:718–722.
   PubMed Web of Science ®Google Scholar
• Tang R, Ding X, Zhu J. Kisspeptin and polycystic ovary syndrome. Front Endocrinol. 2019;298:1–7.
   Google Scholar
• Yilmaz SA, Kerimoglu OS, Pekin AT, et al. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2014;180:56–60.
   PubMed Web of Science ®Google Scholar
• Umayal B, Chandrasekharan NV, Wijesundera WSS, et al. Polycystc ovary syndrome: genetic contributions from the hypothalamic-pituitary-gonadal axis. Int Arch Endocrinol Clin Res. 2018;4:1–8.
   Google Scholar
• Balen AH. Hypersecretion of luteinizing hormone and the polycystic ovary syndrome. Hum Reprod. 1993;8:123–128.
   PubMed Web of Science ®Google Scholar
• Codner E, Iñíguez G, Villarroe C, et al. Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. J Clin Endocrinol Metab. 2007;92:4742–4746.
   PubMed Web of Science ®Google Scholar
• Ali AT. Polycystic ovary syndrome and metabolic syndrome. Ceska Gynekol. 2015;80:279–289.
   PubMedGoogle Scholar
• Zhu S, Zhang B, Jiang X, et al. Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2019;111:168–177.
   Web of Science ®Google Scholar
• Lobo RA, Granger L, Goebelsmann U, et al. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. J Clin Endocrinol Metab. 1981;52:156–158.
   PubMed Web of Science ®Google Scholar
• DeVane GW, Czekala NM, Judd HL, et al. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol. 1975;121:496–500.
   PubMed Web of Science ®Google Scholar
• Waldstreicher J, Santoro NF, Hall JE, et al. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab. 1988;66:165–172.
   PubMed Web of Science ®Google Scholar
• Johansson J, Stener-Victorin E. Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. Evid Based Complement Alternat Med. 2013;2013:762615.
   PubMed Web of Science ®Google Scholar
• Moore AM, Prescott M, Campbell RE. Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome. Endocrinology. 2013;154:796–806.
   PubMed Web of Science ®Google Scholar